Vivace Therapeutics, Inc.
Biotechnology-Research
Website
Industry Category
Business Keywords
Company Description
Vivace Therapeutics, Inc. is at the forefront of biotechnology research, dedicated to pioneering a new era of cancer therapeutics. With industry-leading expertise in the Hippo-YAP pathway, Vivace Therapeutics, Inc. is developing a groundbreaking generation of YAP-TEAD transcription activity inhibitors. This innovative approach targets fundamental mechanisms of cancer, offering significant potential for improved patient outcomes and substantial market impact.
Located in San Mateo, California, Vivace Therapeutics, Inc. operates from its primary address at 1510 Fashion Island Blvd, Suite 310, San Mateo, California 94404, US. The company specializes in drug discovery and small molecules, utilizing a US/China hybrid business model to advance cancer therapeutics. Vivace Therapeutics, Inc. is committed to advancing the field through cutting-edge research and development.
Vivace Therapeutics, Inc. continues to expand its capabilities and impact in the biotechnology sector. We invite the management of Vivace Therapeutics, Inc. to create a customized and exclusive company showcase and product listing on our platform to further enhance their visibility and commercial development.
Vivace Therapeutics, Inc. est à l'avant-garde de la recherche biotechnologique, dédiée à l'inauguration d'une nouvelle ère de thérapies contre le cancer. Forte d'une expertise de pointe dans le domaine de la voie Hippo-YAP, Vivace Therapeutics, Inc. développe une nouvelle génération révolutionnaire d'inhibiteurs de l'activité de transcription YAP-TEAD. Cette approche innovante cible les mécanismes fondamentaux du cancer, offrant un potentiel significatif pour l'amélioration des résultats pour les patients et un impact substantiel sur le marché.
Située à San Mateo, en Californie, Vivace Therapeutics, Inc. opère depuis son adresse principale au 1510 Fashion Island Blvd, Suite 310, San Mateo, California 94404, US. L'entreprise se spécialise dans la découverte de médicaments et les petites molécules, utilisant un modèle commercial hybride États-Unis/Chine pour faire progresser les thérapies contre le cancer. Vivace Therapeutics, Inc. s'engage à faire progresser le domaine grâce à une recherche et un développement de pointe.
Vivace Therapeutics, Inc. continue d'étendre ses capacités et son impact dans le secteur de la biotechnologie. Nous invitons la direction de Vivace Therapeutics, Inc. à créer une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme afin d'améliorer davantage leur visibilité et leur développement commercial.
Key Personnel / Employees
Compare Companies Side by Side
Compare Vivace Therapeutics, Inc. with 3 companies in Biotechnology-Research
| Comparison Field |
Vivace Therapeutics, Inc.Main Company |
Syngene Internationa...View Profile |
Afecta Pharmaceutica...View Profile |
Virtual Discovery, I...View Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 1993 | 2020 | |
|
Company Size
|
— | 5,001-10,000 | 2-10 | 2-10 |
|
City
|
San Mateo, California | Bengaluru, Karnataka | Irvine, California | Boston, MA |
|
Country
|
United States | India | United States | United States |
|
Skills & Keywords
Comparing with main company
|
9 Total Skills
Biotechnology
Cancer Therapeutics
Drug Discovery
Small Molecules
Hippo-YAP Pathway
YAP-TEAD Inhibitors
Pharmaceutical Research
Virtual Biotech
US/China Hybrid Business Model
|
30 Total
30 Unique
Unique Skills:
Analytical Characterization & Quality Control
Analytical Development
Antibody Drug Conjugates
Antibody Generation
Bioanalytical Laboratory Services
Biologics
+24
|
18 Total
1 Common
17 Unique
Match
11%
Common Skills:
Biotechnology
Unique Skills:
505(b)(2)
Artificial Intelligence
Clinical Development
Dermatology
Drug Delivery
Gynecology
+11
|
11 Total
11 Unique
Unique Skills:
Analog Generation
Biotech
Docking
Drug Research
Hit Generation
Lead Optimization
+5
|
4
Total Companies1993
Oldest Founded2
Countries66
Unique SkillsSimilar Companies
Other organizations in the same industry
Anvia Therapeutics
Biotechnology-ResearchTransforming the standard of care in immunology with oral therapies.
SpectrumX
Biotechnology-ResearchWhere Innovations in Science Meets Pharmaceutical Grade Excellence
MImAbs SAS
Biotechnology-ResearchInnovative start up developing monoclonal antibodies in cancer and inflammatory diseases
Alternative Company Names
This company is also known as